Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institut für Diabetes-Technologie (IDT) is a specialized contract research organization (CRO) and research institute based in Ulm, Germany, dedicated to the development and clinical evaluation of diabetes technologies. The institute provides a wide range of services to medical device manufacturers, including clinical trials for glucose sensors and insulin pumps, human factors engineering, and laboratory analysis for glycemic monitoring systems. Affiliated with the University of Ulm, IDT plays a critical role in helping companies meet regulatory requirements such as the Medical Device Regulation (MDR) through rigorous scientific testing. Their expertise encompasses continuous glucose monitoring (CGM), automated insulin delivery (AID) systems, and digital health applications for diabetes management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut für Diabetes-Technologie.